Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy

• Main Authors: Yuxiang Lin (Author), E. Lin (Author), Yan Li (Author), Xiaobin Chen (Author), Minyan Chen (Author), Jun Huang (Author), Wenhui Guo (Author), Lili Chen (Author), Long Wu (Author), Xiang Zhang (Author), Wenzhe Zhang (Author), Xuan Jin (Author), Jie Zhang (Author), Fangmeng Fu (Author), Chuan Wang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Triple-negative breast cancer (TNBC) is characterized by a more aggressive biological behavior and unfavorable outcome. Circulating and histological expression of THBS2 has been demonstrated to be a novel diagnostic and prognostic biomarker in patients with various types of tumors. Howev...